StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.41−0.03 (-0.67%)

Close on Nov 20, 2026Market cap $6.92MP/E –Yield –

Curanex Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Curanex Pharmaceuticals

Curanex Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Curanex Pharmaceuticals figures

See a number that looks wrong?